Financial Toxicity in Patients With Early-stage Breast Cancer

Recruiting now

Conditions studied: Breast Cancer

In brief

Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.

Key facts

Study ID

NCT07354165

Run by

National Cancer Institute, Naples

People needed

864

Starts

2025-09-30

Expected to finish

2034-09-01

Last updated by the study team

2026-01-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent form
• Age > 18 years at the time of study entry
• Histologically confirmed stage I-III invasive breast carcinoma before starting any systemic treatment.

You may not qualify if…

• Stage IV invasive breast carcinoma
• Major cognitive dysfunction or psychiatric disorders
• Any previous systemic treatment for the current breast cancer

Where it is running

• National Cancer Institute of Napoli — Naples, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.